Quarter Financials
Eli Lilly and Company (LLY)
$548.985
-0.78 (-0.14%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Net Income | 1,763 | 1,345 | 1,938 | 1,452 | 953 | 1,903 | 1,726 | 1,110 |
|---|
| Dividend Paid | -1,018 | -1,017 | -884 | -882 | -884 | -886 | -773 | -770 |
|---|
| Retained Earnings | 10,369 | 10,639 | 10,043 | 10,007 | 8,556 | 9,369 | 8,959 | 9,639 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| Capital Expenditure | -836 | -904 | -556 | -620 | -451 | -857 | -394 | -456 |
|---|
| Net PPE | 11,277 | 10,546 | 10,144 | 9,311 | 9,128 | 9,103 | 8,985 | 8,920 |
|---|
|
Year
|
2023 Q2
|
2023 Q1
|
2022 Q4
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
|---|
| New Purchases | -208 | -275 | -131 | -153 | -255 | -169 | -169 | -234 |
|---|
| Intangible and Goodwill | 3,884 | 3,892 | 3,892 | 3,892 | 3,892 | 4,073 | 4,073 | 4,079 |
|---|